(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol

C32H62N4O — CID 56669917

IUPAC(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol
SMILESC[C@H](CO)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](NCCCNCCCCNCCCN)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C32H62N4O/c1-24(23-37)28-10-11-29-27-9-8-25-22-26(12-14-31(25,2)30(27)13-15-32(28,29)3)36-21-7-20-35-18-5-4-17-34-19-6-16-33/h24-30,34-37H,4-23,33H2,1-3H3/t24-,25-,26+,27+,28-,29+,30+,31+,32-/m1/s1
InChIKeyLTJWLCGUIGQSJF-HUYBVNGUSA-N
MW518.88 g/mol
LogP4.93
Rot. Bonds15

About (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol

(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol (PubChem CID 56669917) has the molecular formula C32H62N4O and a molecular weight of 518.88 g/mol. Its IUPAC name is (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol.

Molecular Properties

Compound Name(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol
PubChem CID56669917
Molecular FormulaC32H62N4O
Molecular Weight518.88 g/mol
Exact Mass518.49
IUPAC Name(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol
SMILESC[C@H](CO)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](NCCCNCCCCNCCCN)CC[C@]4(C)[C@H]3CC[C@]12C
InChIInChI=1S/C32H62N4O/c1-24(23-37)28-10-11-29-27-9-8-25-22-26(12-14-31(25,2)30(27)13-15-32(28,29)3)36-21-7-20-35-18-5-4-17-34-19-6-16-33/h24-30,34-37H,4-23,33H2,1-3H3/t24-,25-,26+,27+,28-,29+,30+,31+,32-/m1/s1
InChIKeyLTJWLCGUIGQSJF-HUYBVNGUSA-N
XLogP4.93
TPSA82.34 Ų
H-Bond Donors5
H-Bond Acceptors5
Rotatable Bonds15
Heavy Atoms37
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500518.88
LogP ≤ 54.93
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol?
The IUPAC name of (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol (CID 56669917) is (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol.
What is the SMILES notation for (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol?
The canonical SMILES for (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol is C[C@H](CO)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](NCCCNCCCCNCCCN)CC[C@]4(C)[C@H]3CC[C@]12C.
What is the InChIKey of (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol?
The InChIKey is LTJWLCGUIGQSJF-HUYBVNGUSA-N. The full InChI is InChI=1S/C32H62N4O/c1-24(23-37)28-10-11-29-27-9-8-25-22-26(12-14-31(25,2)30(27)13-15-32(28,29)3)36-21-7-20-35-18-5-4-17-34-19-6-16-33/h24-30,34-37H,4-23,33H2,1-3H3/t24-,25-,26+,27+,28-,29+,30+,31+,32-/m1/s1.
What are the key properties of (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol?
(2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol has a molecular weight of 518.88 g/mol, XLogP of 4.93, 15 rotatable bonds, 5 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-2-[(3S,5R,8R,9S,10S,13S,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]propan-1-ol is sourced from PubChem (CID 56669917), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).